← Leaderboards
Jaclyn Kubala
Weill Medical Coll Of Cornell Univ
$143,424
Attributed
$143,424
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $45K · FY2017–20$50K$37.5K$25K$12.5K$0
'17
'18
'19
'20
Funding mix
By agency
NIH$143,424 · 1
By mechanism
F31$143,424 · 1
Top collaborators
No co-investigators on record.
Most similar at Weill Medical Coll Of Cornell Univ
Same institution · by research overlap
- Yoon-Seong Kim$8,102,385
- Ethel Cesarman$22,572,616
- Pengbo Zhou$14,509,570
- Ming Li$16,447,093
- Alexandre Matov$170,886
Others in their field
Other Emerging Leaders on “Fibroblasts”
- Costas Andreas Lyssiotis · University Of Michigan At Ann Arbor$6,921,511
- Leonard Freedman · Leidos Biomedical Research, Inc.$5,982,481
- Afonso C Silva · University Of Pittsburgh At Pittsburgh$4,861,794
- Kaifu Chen · Methodist Hospital Research Institute$4,859,015
- Giovanni Ligresti · Mayo Clinic Rochester$4,830,216
- Brian Prindle$4,494,879
Research focus
FibroblastsGenome-WideAffectCancer PatientCancer PharmacologyAmerican Cancer SocietyCell Culture TechniquesCancer EtiologyCellsCell SurvivalCessation Of LifeCharacteristicsClear CellCarcinogenesisComplexCurative TreatmentsDiagnostic FactorCell ProliferationDoctor Of PhilosophyDrug Delivery SystemsEffective TherapyEncapsulatedExperimental StudyGlycolysis
Grant awards (4)
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma$9,840
F31 · FY2020 · CA · contact PI
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma$45,016
F31 · FY2019 · CA · contact PI
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma$44,524
F31 · FY2018 · CA · contact PI
The Role of NDUFA4L2 in Clear Cell Renal Cell Carcinoma$44,044
F31 · FY2017 · CA · contact PI